News for OptimizeRx Corporation (OPRX)

OptimizeRx Corporation (NASDAQ:OPRX) Q4 2024 Results Conference Call March 12, 2025 8:30 AM ETCompany ParticipantsSteve Silvestro - PresidentEdward Stelmakh...

Q4 revenue of $32.3 million, increasing 14% year-over-yearQ4 gross profit increased 23% year-over-year to $22.0 million with gross margin of 68%Company generate

Massachusetts-based iRobot Corporation (IRBT) is down over 35 percent in Wednesday's pre-market trading. The following are some of the other stocks making big moves in Wednesday's pre-market trading.

OptimizeRx (OPRX) delivered earnings and revenue surprises of 20% and 9.58%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

OptimizeRx press release (OPRX): Q4 Non-GAAP EPS of $0.30 beats by $0.03. Revenue of $32.3M (+13.7% Y/Y) beats by $1.94M. Adjusted EBITDA for the fourth quarter came in at $8.8 million

No Stockholder Action Required at this Time WALTHAM, Mass., March 11, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the ”œCompany”) ( OPRX), a leading provi

OptimizeRx (OPRX) has confirmed that it has received a purported notice of nominations from a stockholder, Whetstone Capital Advisors, regarding its intention t

Silvestro has a demonstrated record of accelerating revenue growth, expanding brand relevance, and building a market-leading team WALTHAM, Mass., March 10, 2

OptimizeRX (OPRX) gains as a holder wants the company to explore a sale

OptimizeRx downgraded to "sector perform" by RBC amid slower growth outlook

OptimizeRx CEO to step down, interim successor named

OptimizeRx Corporation (NASDAQ:OPRX) Q3 2024 Results Earnings Conference Call November 13, 2024 4:30 PM ETCompany ParticipantsWilliam Febbo - Chief...

OptimizeRx (OPRX) delivered earnings and revenue surprises of 100% and 14.55%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

OptimizeRx (OPRX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

WALTHAM, Mass., Oct. 31, 2024 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions...

Optimizerx stock hits 52-week low at $6.29 amid market shifts

OptimizeRx (OPRX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

WALTHAM, Mass., Sept. 10, 2024 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), the leading provider of healthcare technology...

The availability of Micro-Neighborhood® Targeting on the Company’s Dynamic Audience Activation Platform meets the demand of life sciences marketers by...